Vertex Cystic Fibrosis Drug Improves Breathing for 28 Days

Biotech, Cystic Fibrosis, VX-770 Luke Timmerman wrote: Vertex Pharmaceuticals has some good news this morning on its experimental drug for cystic fibrosis. The treatment, taken an oral pill, helped patients breathe better for 28 days at both a high and low dose that did a placebo, without any serious side effects. The findings for VX-770 were from a mid-stage study of 19 cystic fibrosis patients with a specific, and rare, mutation called G551D. The results confirm an earlier look at the data

Read this article...